This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Jan;1(1):13-22.

doi: 10.1046/j.1463-1326.1999.00009.x.

UKPDS and beyond: into the next millennium. United Kingdom Prospective Diabetes Study

A J Krentz¹

Affiliations

PMID: 11221807
DOI: 10.1046/j.1463-1326.1999.00009.x

Review

UKPDS and beyond: into the next millennium. United Kingdom Prospective Diabetes Study

A J Krentz. Diabetes Obes Metab. 1999 Jan.

. 1999 Jan;1(1):13-22.

doi: 10.1046/j.1463-1326.1999.00009.x.

Author

A J Krentz¹

Affiliation

¹ Department of Diabetes and Endocrinology, Southampton General Hospital, UK. a.j.krentz@soton.ac.uk

PMID: 11221807
DOI: 10.1046/j.1463-1326.1999.00009.x

No abstract available

PubMed Disclaimer

Similar articles

Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study.
Nathan DM. Nathan DM. Lancet. 1998 Sep 12;352(9131):832-3. doi: 10.1016/s0140-6736(98)22937-0. Lancet. 1998. PMID: 9742972 No abstract available.
The continuing legacy of the United Kingdom Prospective Diabetes Study.
Davis TM, Colagiuri S; United Kingdom Prospective Diabetes Study. Davis TM, et al. Med J Aust. 2004 Feb 2;180(3):104-5. doi: 10.5694/j.1326-5377.2004.tb05828.x. Med J Aust. 2004. PMID: 14748669 No abstract available.
The treatment of type 2 diabetes: good news from the UK.
Smith RB, Mann JI. Smith RB, et al. N Z Med J. 1999 May 14;112(1087):149-50. N Z Med J. 1999. PMID: 10378808 No abstract available.
Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
Holman RR. Holman RR. Metabolism. 2006 May;55(5 Suppl 1):S2-5. doi: 10.1016/j.metabol.2006.02.006. Metabolism. 2006. PMID: 16631806 Review.
Role of metformin in type II diabetes.
Epstein S. Epstein S. Cleve Clin J Med. 1995 Sep-Oct;62(5):278-9. doi: 10.3949/ccjm.62.5.278. Cleve Clin J Med. 1995. PMID: 7586481 Review. No abstract available.

See all similar articles

Cited by

New drugs for type 2 diabetes mellitus: what is their place in therapy?
Krentz AJ, Patel MB, Bailey CJ. Krentz AJ, et al. Drugs. 2008;68(15):2131-62. doi: 10.2165/00003495-200868150-00005. Drugs. 2008. PMID: 18840004 Review.
Unexpected yes- and no-answering behaviour in the discrete choice approach to elicit willingness to pay: a methodological comparison with payment cards.
Hammerschmidt T, Zeitler HP, Leidl R. Hammerschmidt T, et al. Int J Health Care Finance Econ. 2003 Sep;3(3):147-66. doi: 10.1023/a:1025341318666. Int J Health Care Finance Econ. 2003. PMID: 14625997
Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia.
Pruski M, Krysiak R, Okopien B. Pruski M, et al. Diabetes Care. 2009 Aug;32(8):1421-4. doi: 10.2337/dc08-2335. Epub 2009 May 12. Diabetes Care. 2009. PMID: 19435959 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information